Hari Menon

2.5k total citations
46 papers, 1.2k citations indexed

About

Hari Menon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Hari Menon has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Hari Menon's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Hari Menon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Hari Menon collaborates with scholars based in United States, India and China. Hari Menon's co-authors include James W. Welsh, María Angélica Cortez, Hampartsoum B. Barsoumian, Rishab Ramapriyan, Vivek Verma, Dawei Chen, Ahmed Younes, Joe Y. Chang, Mehmet Altan and Mauricio S. Caetano and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Hari Menon

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hari Menon United States	17	661	398	330	321	227	46	1.2k
Max M. Wattenberg United States	14	843 1.3×	251 0.6×	505 1.5×	240 0.7×	250 1.1×	25	1.2k
Claire Lhuillier United States	12	1.2k 1.9×	370 0.9×	927 2.8×	263 0.8×	147 0.6×	15	1.7k
Zishuo I. Hu United States	11	748 1.1×	378 0.9×	197 0.6×	217 0.7×	415 1.8×	12	1.2k
Hao-Yuan Mo China	17	667 1.0×	254 0.6×	188 0.6×	388 1.2×	231 1.0×	34	1.3k
Kristina H. Young United States	16	959 1.5×	244 0.6×	676 2.0×	166 0.5×	104 0.5×	38	1.3k
Edmund Poon United Kingdom	10	1.3k 2.0×	457 1.1×	732 2.2×	199 0.6×	86 0.4×	18	1.7k
Youjin Lee South Korea	8	912 1.4×	361 0.9×	564 1.7×	189 0.6×	73 0.3×	10	1.3k
Hao‐Yuan Mo China	16	598 0.9×	224 0.6×	129 0.4×	294 0.9×	278 1.2×	37	1.3k
Noriyuki Okonogi Japan	19	440 0.7×	403 1.0×	221 0.7×	149 0.5×	100 0.4×	88	1.1k
Shugeng Gao China	21	529 0.8×	783 2.0×	148 0.4×	507 1.6×	447 2.0×	99	1.5k

Countries citing papers authored by Hari Menon

Since Specialization

Citations

This map shows the geographic impact of Hari Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari Menon more than expected).

Fields of papers citing papers by Hari Menon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hari Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari Menon. The network helps show where Hari Menon may publish in the future.

Co-authorship network of co-authors of Hari Menon

This figure shows the co-authorship network connecting the top 25 collaborators of Hari Menon. A scholar is included among the top collaborators of Hari Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hari Menon. Hari Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blum, Steven I., Jessica R. Miller, Kristin Bradley, et al.. (2024). Dosimetric evaluation of adaptive planning for five-fraction gynecologic template-based interstitial brachytherapy. Brachytherapy. 23(6). 668–675. 1 indexed citations

Jain, Hasmukh, Akhil Kapoor, Manju Sengar, et al.. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 37(3). 379–385. 3 indexed citations

Chen, Dawei, Hampartsoum B. Barsoumian, Liangpeng Yang, et al.. (2020). SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer. Cancer Immunology Research. 8(7). 883–894. 63 indexed citations

Patel, Roshal R., Ethan B. Ludmir, Joseph A. Miccio, et al.. (2020). Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review. Practical Radiation Oncology. 10(6). 423–433. 7 indexed citations

Cortez, María Angélica, Fatemeh Masrorpour, Cristina Ivan, et al.. (2020). Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nature Communications. 11(1). 4840–4840. 29 indexed citations

Younes, Ahmed, Hampartsoum B. Barsoumian, Duygu Sezen, et al.. (2020). Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity. Translational Oncology. 14(2). 100983–100983. 20 indexed citations

Caetano, Mauricio S., Ahmed Younes, Hampartsoum B. Barsoumian, et al.. (2019). Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clinical Cancer Research. 25(24). 7576–7584. 54 indexed citations

Buetow, Kenneth H., Hari Menon, Haiyan Cui, et al.. (2019). High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma. The Journal of Immunology. 203(10). 2577–2587. 26 indexed citations

Welsh, James W., John V. Heymach, Dawei Chen, et al.. (2019). Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 15(2). 266–273. 57 indexed citations

10.

Li, Ailin, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, et al.. (2019). IDO1 Inhibition Overcomes Radiation-Induced “Rebound Immune Suppression” by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. International Journal of Radiation Oncology*Biology*Physics. 104(4). 903–912. 40 indexed citations

11.

Menon, Hari, Rishab Ramapriyan, Taylor R. Cushman, et al.. (2019). Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Frontiers in Immunology. 10. 193–193. 113 indexed citations

12.

Augustyn, Alexander, Todd A. Pezzi, Hari Menon, et al.. (2019). Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab. Frontiers in Oncology. 9. 223–223. 20 indexed citations

13.

Menon, Hari, Chunxiao Guo, Vivek Verma, & Charles B. Simone. (2019). The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation. PET Clinics. 15(1). 45–53. 9 indexed citations

14.

Ramapriyan, Rishab, Mauricio S. Caetano, Hampartsoum B. Barsoumian, et al.. (2018). Altered cancer metabolism in mechanisms of immunotherapy resistance. Pharmacology & Therapeutics. 195. 162–171. 118 indexed citations

15.

Yanamandra, Uday, Navin Khattry, Shaji Kumar, et al.. (2017). Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference. Indian Journal of Hematology and Blood Transfusion. 33(1). 15–21. 12 indexed citations

16.

Glisson, Bonnie S., Andrzej Każarnowicz, Kristiaan Nackaerts, et al.. (2013). A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 2 STUDY OF GANITUMAB OR RILOTUMUMAB WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (SCLC). Journal of Thoracic Oncology. 8. 4 indexed citations

17.

Khanna, Nehal, Hari Menon, Manju Sengar, et al.. (2013). Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?. Leukemia & lymphoma. 55(10). 2356–2361. 7 indexed citations

18.

Malhotra, Gaurav, et al.. (2008). Bronchoalveolar Carcinoma of Lung Masquerading as Iodine Avid Metastasis in a Patient With Minimally Invasive Follicular Carcinoma of Thyroid. Clinical Nuclear Medicine. 33(1). 26–29. 6 indexed citations

19.

Agarwal, J.P., Tapas K. Das Gupta, Purvish M. Parikh, et al.. (2008). Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review. British Journal of Radiology. 81(964). e120–e122. 8 indexed citations

20.

Thomas, M. Kate, et al.. (2007). Anesthesia considerations in large-volume lipoplasty. Aesthetic Surgery Journal. 27(6). 607–611. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact